Inflammation, statins, and outcome after ischemic stroke [9]

Stroke

Volumn 32, Issue 10, 2001, Pages 2446-2447

  Di Napoli, M ^a   Papa, F ^a  

^a Casa di Cura Villa Pini d'Abruzzo ^*  (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ATORVASTATIN; C REACTIVE PROTEIN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PRAVASTATIN; SIMVASTATIN; STATINE DERIVATIVE; TRIACYLGLYCEROL;

ADULT; AGED; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FOLLOW UP; HUMAN; INFLAMMATION; LETTER; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEUROPROTECTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; TREATMENT OUTCOME;

EID: 0034787965     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/str.32.10.2446-a     Document Type: Letter

References (8)

1. Does pretreatment with statins improve clinical outcome after stroke? A pilot case-referent study
2. HGM-CoA reductase inhibitors (statins): A promising approach to stroke prevention
3. Prognostic influence of increased C-reactive protein and fibrinogen levels in ischemic stroke
4. C-reactive protein in ischemic stroke: An independent prognostic factor
5. Periodontal disease, C-reactive protein, and ischemic stroke
6. C-reactive protein as a cardiovascular risk factor: More than an epiphenomenon?
7. Neuroprotective properties of statins in cerebral ischemia and stroke
8. Treating dyslipidaemia in primary care: The gap between policy and reality is large in UK